Report of the Special Commission on Public Health Effects of Xylazine (pursuant to Section 36 of Chapter 285 of the Acts of 2024) submitting its recommendations and final report on ways to address the public health and safety concerns posed by the proliferation of xylazine as an additive to illicit drugs including, but not limited to, fentanyl